Dual‐Targeting BCMA – CD19 CAR ‐T Cell Therapy in Systemic Lupus Erythematosus: Single‐Cell and Immune Repertoire Analysis Reveals Mechanisms of Immune Reconstitution
Arthritis & Rheumatology · 2026-10 · 78 (10) · 2110-2123
DOI: 10.1002/art.70117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 02.04.2026. Verfasst von Zhenghao He und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Zhongshan People's Hospital, Zhongshan, Guangdong, People's Republic of China. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Antigens, CD19, B-Cell Maturation Antigen, Immunotherapy, Adoptive. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Medical Science Research Foundation of Guangdong Province of China.
Abstract (Originalsprache)
Objective
To investigate peripheral immune reconstitution following BCMA–CD19 dual‐targeting CAR‐T therapy in patients with systemic lupus erythematosus (SLE).
Methods
Single‐cell RNA sequencing and parallel B cell receptor (BCR) and T cell receptor sequencing were performed on peripheral blood mononuclear cells from five patients with SLE before infusion and after peripheral B cell reconstitution (median 90 days postinfusion). These data were integrated with public datasets from seven patients with SLE treated with CD19 single‐targeting CAR‐T and three healthy controls for comparative analysis (total N = 15 subjects; 176,182 single cells analyzed).
Results
Dual‐targeting CAR‐T induced marked depletion of B‐lineage populations, including plasma‐lineage clusters that persisted after CD19 therapy. Specifically, cluster 2 decreased from 10.70% to 2.67% and cluster 3 from 9.55% to 3.12% in the dual‐targeting cohort, whereas cluster 3 increased (6.78%–12.19%) in the single‐targeting comparator. In B cells, dual targeting produced greater suppression of RIG‐I/MDA5 and type I interferon transcriptional programs than single‐targeting therapy. BCR repertoires shifted toward an IGHM‐dominant (49.83%–89.19%, P < 0.05), naïve‐biased profile, with contraction of pre‐enriched class‐switched clones and restoration of diversity toward healthy‐like profiles. Clinical improvement was significant (mean SLE Disease Activity Index decreased from 9.6 to 2.4, P < 0.05), paralleling these molecular changes.
Conclusion
BCMA–CD19 dual CAR‐T therapy was associated with deeper depletion of plasma‐lineage compartments and a tendency toward more pronounced reversal of SLE‐associated molecular signatures. This exploratory finding suggests a potential advantage of dual targeting in achieving a more comprehensive humoral reset in SLE, which warrants further direct comparative studies to determine clinical superiority. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Plastic Surgery, Zhongshan People's Hospital, Zhongshan, Guangdong, People's Republic of China.
- Department of Dermatology, Second Xiangya Hospital, Hunan Key Laboratory of Medical Epigenomics, Clinical Medical Research Center of Major Skin Diseases and Skin Health of Hunan Province, Central South University, Chang…
- Institute of Advanced Diagnostic and Clinical Medicine, Zhongshan People's Hospital, Zhongshan, Guangdong, People's Republic of China.
- Department of Rheumatology and Immunology, Zhongshan People's Hospital, Zhongshan, Guangdong, People's Republic of China.
ORCID-Profile: Ming Hong
Förderung
- Medical Science Research Foundation of Guangdong Province of China
Zitieren
APA
He, Z., Wang, W., Li, Q., Ding, S., Wang, M., & Hong, M. (2026). Dual‐Targeting BCMA – CD19 CAR ‐T Cell Therapy in Systemic Lupus Erythematosus: Single‐Cell and Immune Repertoire Analysis Reveals Mechanisms of Immune Reconstitution. Arthritis & Rheumatology, 78(10), 2110-2123. https://doi.org/10.1002/art.70117
Vancouver
He Z, Wang W, Li Q, Ding S, Wang M, Hong M. Dual‐Targeting BCMA – CD19 CAR ‐T Cell Therapy in Systemic Lupus Erythematosus: Single‐Cell and Immune Repertoire Analysis Reveals Mechanisms of Immune Reconstitution. Arthritis & Rheumatology. 2026;78(10):2110-2123. doi:10.1002/art.70117
BibTeX
@article{He2026,
author = {He, Zhenghao and Wang, Weijia and Li, Qianwen and Ding, Shihao and Wang, Mingxia and Hong, Ming},
title = {Dual‐Targeting BCMA – CD19 CAR ‐T Cell Therapy in Systemic Lupus Erythematosus: Single‐Cell and Immune Repertoire Analysis Reveals Mechanisms of Immune Reconstitution},
journal = {Arthritis & Rheumatology},
year = {2026},
volume = {78},
number = {10},
pages = {2110--2123},
doi = {10.1002/art.70117}
}
EUVIMED